Agnihotra as an inexpensive method to treat HIV/AIDS – A pilot study
Integrative Medicine Case Reports · 2021
DOI: 10.38205/imcr.020106 ↗Kurz gefasst
Fachartikel in der Zeitschrift Integrative Medicine Case Reports, 2021. Verfasst von S. A. Ramadass und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Despite four decades of searching, no vaccine exists yet for HIV/AIDS, and it is still a big problem in many countries of the world.
Purpose
Finding a simple method which is affordable, and which could help avoid side effects which the commonly used antiretroviral drugs often show, is the need of the moment.
Method
A group of HIV positive children have been performing daily sunrise/sunset Agnihotra themselves under supervision for two years. Data were collected on viral load and CD4 counts before and after that. Repeated measure ANOVA was employed to find out the effectiveness of Agnihotra on reduction of viral load and increase in CD4 count.
Results
Data shows general health improved measurably as viral load went down and CD4 values increased.
Conclusion
These preliminary results show good potential of Agnihotra for HIV/AIDS patients and a randomized controlled trail is suggested.
Zitieren
APA
Ramadass, S. A., D’souza, L., Pandit, K., S, M. K., & Berk, U. (2021). Agnihotra as an inexpensive method to treat HIV/AIDS – A pilot study. Integrative Medicine Case Reports. https://doi.org/10.38205/imcr.020106
Vancouver
Ramadass SA, D’souza L, Pandit K, S MK, Berk U. Agnihotra as an inexpensive method to treat HIV/AIDS – A pilot study. Integrative Medicine Case Reports. 2021. doi:10.38205/imcr.020106
BibTeX
@article{Ramadass2021,
author = {Ramadass, S. A. and D’souza, Lancy and Pandit, Karthik and S, Madhu Karnat and Berk, Ulrich},
title = {Agnihotra as an inexpensive method to treat HIV/AIDS – A pilot study},
journal = {Integrative Medicine Case Reports},
year = {2021},
doi = {10.38205/imcr.020106}
}
EUVIMED